OncoSil Medical Ltd (ASX: OSL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
OncoSil Medical Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$13.53 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
2.26 billion
Earnings per share
-0.008
Dividend per share
N/A
Year To Date Return
-17.65%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
OncoSil Medical Ltd (ASX: OSL)
Latest News
Healthcare Shares
The OncoSil Medical share price is booming 66%. Here's why
Healthcare Shares
Why is the OncoSil Medical (ASX:OSL) share price surging 18% today?
Healthcare Shares
Why the OncoSil (ASX:OSL) share price finished the day higher today
Share Market News
Here's why the OncoSil Medical (ASX:OSL) share price has jumped 10% today
OSL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About OncoSil Medical Ltd
OncoSil Medical Ltd is an Australian based medical device company focused on localized radiation treatments for patients with pancreatic and bile duct cancer. The product includes OncoSil, a silicon and phosphorus (p32) beta emitter radiation therapy for the treatment of pancreatic cancer.
OSL Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 19 Apr 2024 | $0.01 | $0.00 | 0.00% | 2,555,969 | $0.01 | $0.01 | $0.01 |
| 18 Apr 2024 | $0.01 | $0.00 | 0.00% | 12,870,397 | $0.01 | $0.01 | $0.01 |
| 17 Apr 2024 | $0.01 | $0.00 | 0.00% | 1,080,830 | $0.01 | $0.01 | $0.01 |
| 16 Apr 2024 | $0.01 | $0.00 | 0.00% | 355,639 | $0.01 | $0.01 | $0.01 |
| 15 Apr 2024 | $0.01 | $0.00 | 0.00% | 6,571,232 | $0.01 | $0.01 | $0.01 |
| 12 Apr 2024 | $0.01 | $0.00 | 0.00% | 10,807,190 | $0.01 | $0.01 | $0.01 |
| 11 Apr 2024 | $0.01 | $0.00 | 0.00% | 700,000 | $0.01 | $0.01 | $0.01 |
| 10 Apr 2024 | $0.01 | $0.00 | 0.00% | 1,885,000 | $0.01 | $0.01 | $0.01 |
| 09 Apr 2024 | $0.01 | $0.00 | 0.00% | 1,570,337 | $0.01 | $0.01 | $0.01 |
| 08 Apr 2024 | $0.01 | $0.00 | 0.00% | 2,424,834 | $0.01 | $0.01 | $0.01 |
| 05 Apr 2024 | $0.01 | $0.00 | 0.00% | 34,183,618 | $0.01 | $0.01 | $0.01 |
| 04 Apr 2024 | $0.01 | $0.00 | 0.00% | 2,187,400 | $0.01 | $0.01 | $0.01 |
| 03 Apr 2024 | $0.01 | $0.00 | 0.00% | 1,099,999 | $0.01 | $0.01 | $0.01 |
| 02 Apr 2024 | $0.01 | $0.00 | 0.00% | 892,191 | $0.01 | $0.01 | $0.01 |
| 28 Mar 2024 | $0.01 | $0.00 | 0.00% | 660,000 | $0.01 | $0.01 | $0.01 |
| 27 Mar 2024 | $0.01 | $0.00 | 0.00% | 2,327,785 | $0.01 | $0.01 | $0.01 |
| 26 Mar 2024 | $0.01 | $0.00 | 0.00% | 704,911 | $0.01 | $0.01 | $0.01 |
| 25 Mar 2024 | $0.01 | $0.00 | 0.00% | 2,066,537 | $0.01 | $0.01 | $0.01 |
| 22 Mar 2024 | $0.01 | $0.00 | 0.00% | 917,407 | $0.01 | $0.01 | $0.01 |
| 21 Mar 2024 | $0.01 | $0.00 | 0.00% | 15,256,219 | $0.01 | $0.01 | $0.01 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 19 Dec 2023 | Nigel Lange | Issued | 91,500,000 | $366,000 |
Issue of securities. 96,811,428 Rights, Non-cash
|
| 19 Dec 2023 | Gabriel Liberatore | Issued | 3,000,000 | $21,000 |
Issue of options. Non-cash
|
| 19 Dec 2023 | Doug Cubbin | Issued | 5,000,000 | $35,000 |
Issue of options. Non-cash
|
| 30 Jun 2023 | Otto Buttula | Sell | 5,307,693 | $63,678 |
On-market trade.
|
| 11 May 2023 | Brian Leedman | Issued | 500,000 | $5,000 |
Rights issue.
|
| 11 May 2023 | Brian Leedman | Issued | 500,000 | $5,000 |
Rights issue.
|
| 11 May 2023 | Nigel Lange | Issued | 1,000,000 | $10,000 |
Rights issue.
|
| 11 May 2023 | Nigel Lange | Issued | 1,000,000 | $10,000 |
Rights issue.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Nigel Lange | Chief Executive OfficerManaging Director | Jan 2021 |
Mr Lange brings with him over 30 years of experience in the medical devices industry. Since 2003, Nigel has held various leadership roles with Sirtex Medical, a global leader in brachytherapy treatment for liver cancer. From 2003, Nigel served as Chief Executive Officer of Sirtex's European business, responsible for establishing their brachytherapy device in over 300 centres across Europe and Middle East.
|
| Dr Gabriel Liberatore | Non-Executive Director | Jul 2023 |
Dr Liberatore is a biopharmaceutical executive with over 25 years experience in senior Business Development, R&D and strategic operational management positions including taking products to market. Until recently, he was the Group Chief Operating Officer at Telix Pharmaceuticals (ASX:TLX) a global biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals. Currently, Dr Liberatore is a Strategic Advisor to GlyTherix Ltd, an Australian immuno-oncology company specializing in developing antibody radiopharmaceuticals for solid tumours.
|
| Mr Doug Cubbin | Non-Executive Director | Aug 2023 |
Mr Cubbin is a biopharmaceutical executive with over 30 years' experience in senior executive, CFO, Director and Chair roles, across varied industries. Mr Cubbin has also served as Chairman of various boards, including Australian Nuclear Science and Technology Organisation (ANSTO) Nuclear Medicine.
|
| Christian Dal Cin | Chief Financial OfficerCompany Secretary | Jun 2023 |
-
|
| Christian Dal Cin | Chief Financial OfficerCompany Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Mrs Sarah Cameron | 118,661,215 | 6.01% |
| Alua Capital Pty Ltd | 47,653,847 | 2.41% |
| Bannaby Investments Pty Limited <Bannaby Super Fund A/C> | 46,000,000 | 2.33% |
| Peter Kyros Pty Ltd Kyros Sf A/C> | 44,656,780 | 2.26% |
| Hsbc Custody Nominees (Australia) Limited | 38,076,479 | 1.93% |
| Citicorp Nominees Pty Limited | 35,052,240 | 1.77% |
| Myconsulting Pty Ltd | 34,000,000 | 1.72% |
| Mr Gregory Joseph Harris | 32,999,930 | 1.67% |
| Newfound Investments Pty Ltd <Newfound Superannuation A/C> | 32,307,694 | 1.64% |
| Sunset Capital Management Pty Ltd <Sunset Superfund A/C> | 29,000,000 | 1.47% |
| Netwealth Investments Limited <Wrap Services A/C> | 27,228,094 | 1.38% |
| Tisia Nominees Pty Ltd <Henderson Family A/C> | 25,845,965 | 1.31% |
| Jk Nominees Pty Ltd <The Jk A/C> | 25,000,000 | 1.27% |
| The Trust Company (Australia) Limited <Mbf A/C> | 23,000,000 | 1.16% |
| Cabletime Pty Ltd <Ingodwe A/C> | 22,553,848 | 1.14% |
| Rojo Nero Capital Pty Ltd | 19,360,127 | 0.98% |
| Rogers Sf Management Pty Ltd <Rogers Super Fund A/C> | 19,089,355 | 0.97% |
| Ardroy Securities Pty Ltd <Cameron Investment Unit A/C> | 16,114,819 | 0.82% |
| Mr Peter Barrett Capp <Capp Family A/C> | 15,000,000 | 0.76% |
| MWCD Pty Ltd <Gww Super Fund A/C> | 14,553,100 | 0.74% |
